// App-Quantinova.ai

1520 : Rituximab and Tocilizumab and Their Effect on Lung Disease Progression in Scleroderma. a Retrospective Cohort Study at a Single Centre

Researchers

Presenter

  • Voon Ong

Principal Investigators

  • Nina Goldman

  • Aoife Tynan

  • Shivani Shah

  • Claire Beesley

  • Rizgar Mageed

  • Chris Denton

Medical Centers

  • Kings College London, London, United Kingdom

  • Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom

  • Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

  • UCL Med Schl Royal Free Campus, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

  • Rituximab

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved